Calyxt Licenses New Technology for Greater Efficiency in Gene-Edited Plants
Calyxt Licenses New Enabling Technology from University of Minnesota for Greater Efficiency in Gene-Edited Plants Unique Technology Has Potential to Reduce Gene-Edited Plant Production Timelines & Increase Speed to Market ROSEVILLE, Minn.–(BUSINESS...
Cannabis and Hemp Stocks: How do you Invest Now?
Cannabis and Hemp Stocks: How do you Invest Now? Analysts predict the cannabis and hemp industry will surpass $75 billion dollars in less than a decade. The time to invest in cannabis and hemp is now. In fact, there’s never been a better time in history to start...
Therapix Biosciences Ltd. Announces Shareholder Conference Call
Therapix Biosciences Ltd. Announces Shareholder Conference Call TEL AVIV, Israel, March 25, 2020 /PRNewswire/ — Therapix Biosciences Ltd. (Nasdaq: TRPX) (the “Company”), a specialty, clinical-stage pharmaceutical company focusing on the development...
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Completes Acquisition of Oncology Research and Development Company Sapphire Biotech, Inc.
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Completes Acquisition of Oncology Research and Development Company Sapphire Biotech, Inc. SAN DIEGO, March 24, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”),...
InMed Submits Clinical Trial Application to Evaluate INM-755 in Second Phase 1 Trial
InMed Submits Clinical Trial Application to Evaluate INM-755 in Second Phase 1 Trial VANCOUVER, March 24, 2020 /PRNewswire/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN;OTCQX:IMLFF), a clinical stage pharmaceutical...Cannin Monthly Subscription with Trading Alerts
Get advance notice of profitable cannabis & hemp stock trades. Use our machine learning algorithm to start profiting from this explosive industry.
$99 / month after 30-day trial.
Still unsure? Schedule demo at info@cannin.com
or call 720-254-1374